Health Care & Life Sciences » Pharmaceuticals | Sino Biopharmaceutical Ltd.

Sino Biopharmaceutical Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,137
2,801
3,444
3,743
4,838
13,537
Depreciation, Depletion & Amortization
224
259
353
345
370
1,366
Other Funds
307
436
557
687
919
8,698
Funds from Operations
1,840
2,445
3,363
3,328
4,887
6,206
Changes in Working Capital
89
385
545
377
497
288
Net Operating Cash Flow
1,752
2,830
2,818
3,705
5,384
6,494
Capital Expenditures
583
638
1,337
1,044
1,684
Sale of Fixed Assets & Businesses
19
29
53
17
235
Purchase/Sale of Investments
210
1,493
3,268
1,713
1,238
Net Investing Cash Flow
823
2,999
2,497
2,900
3,363
Cash Dividends Paid - Total
247
321
296
439
519
Issuance/Reduction of Debt, Net
21
1,637
2
1,872
112
Net Financing Cash Flow
533
880
851
746
1,550
Net Change in Cash
443
632
736
1,614
219
Free Cash Flow
1,251
2,383
1,553
2,795
4,163
Net Assets from Acquisitions
10
74
47
7
406
Other Sources
-
1
2,102
-
-
Exchange Rate Effect
48
80
206
62
251
Other Uses
39
824
-
152
271

About Sino Biopharmaceutical

View Profile
Address
Unit 09, 41st Floor, Office Tower
Hong Kong
Hong Kong
Employees -
Website http://www.sinobiopharm.com
Updated 07/08/2019
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products.